Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. C. Brady
Biomarker Signatures Correlate With Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Circulating VEGF and eNOS Variations as Predictors of Outcome in Metastatic Colorectal Cancer Patients Receiving Bevacizumab
Scientific Reports
Multidisciplinary
Anticoagulant Therapy for Venous Thromboembolism Detected by Doppler Ultrasound in Patients With Metastatic Colorectal Cancer Receiving Bevacizumab
OncoTargets and Therapy
Oncology
Pharmacology
Utilization of Bevacizumab Among Medicare Patients With Colorectal Cancer Receiving Chemotherapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients
Scientific Reports
Multidisciplinary
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
Frontiers in Oncology
Cancer Research
Oncology
Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology